SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

  • This share is currently suspended. It was suspended at a price of 0.125
  • There is currently no data for CRV

Directorate Change

23 Nov 2007 07:01

Medsea Estates Group PLC23 November 2007 Medsea Estates Group plc ("Medsea" or "the Company") Board Appointment Medsea Estates Group plc (AIM: MEA), the Mediterranean-based property group, ispleased to announce the appointment of Neil Emmet Craven as a non-executivedirector with effect from 1st December 2007. Mr Craven holds 1 million shares inthe Company representing 1.3% of the issued shares. Neil Craven, 39, has many years' experience at senior management levels intelecommunications and fund management. He was part of the founding managementteam of Carrier1 International S.A., a NASDAQ-listed pan-European provider oftelecoms services to internet service providers and other telecom companieswhere he served as vice-president in charge of business development from 1998 to2003. During this time, he was also responsible for the pan-European broadbandbusiness and for capital expenditure across the group. In 2003, he moved intofund management and from late 2004 to the end of 2006 he was a partner in aSwiss-based asset management and corporate finance boutique where he wasresponsible for establishing and managing a hedge fund focussed on specialsituations and small cap equities. He is currently a private investor focusingon small-cap equities. He holds a degree in computer engineering from TrinityCollege Dublin and an MBA from the Rotterdam School of Management. - Ends - For further information:Medsea Estates Group plcTony Gatehouse, Chairman Tel: +34 96 570 40 02Juan Carlos Rodriguez Martinez, Chief Executive HB CorporateEdward Hutton / Rachel Kane/Imran Ahmad Tel: +44 (0) 20 7510 8600 Media enquiries:Threadneedle CommunicationsAlex White/Josh Royston Tel: +44 (0) 20 7936 9665 Appendix re AIM Rules requirements: In the last five years, Mr Craven was a partner of Azemos Partner AG (October 2004 to December 2006) and managing director of Carrier1 International GmbH ("GmbH"), the Swiss subsidiary of Carrier1 International S.A (January 2002 to February 2003). He was appointed to the latter role shortly before GmbH filed for protection from creditors resulting from Carrier1 International S.A.'s filing for insolvency in February 2002. In that role, he led the liquidation of the group's assets and businesses as well as the reduction of its liabilities. The insolvency resulted from the inability of Carrier1 International S.A. (for technical reasons under Luxembourg law) to proceed with a financial restructuring with bondholders. There is no further information to disclose in accordance with Schedule Two (g) of the AIM Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jul 20257:00 amRNSCancellation - Craven House Capital PLC
23rd Jun 202510:30 amRNSWithdrawl of 'Stmt re Share Price Movement' RNS
23rd Jun 202510:05 amRNSStatement re Share Price Movement
23rd Jun 20257:30 amRNSSuspension - Craven House Capital Plc
23rd Jun 20257:00 amRNSResignation of Nominated Adviser
27th Feb 20257:00 amRNSInterim Results
7th Feb 20254:22 pmRNSTR-1: Notification of major holdings
16th Dec 20242:42 pmRNSResult of AGM
15th Nov 20247:00 amRNSAnnual Results For Year Ended 31 May 2024
10th Sep 20247:00 amRNSInvestee company update: RoseMonkey Ltd
27th Aug 20247:00 amRNSTR-1: Notification of major holdings
23rd Aug 20242:19 pmRNSTR-1: notification of major holdings
5th Jun 20247:00 amRNSInvestee Companies' Update: Bio Vitos
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.